Pearly sheen not just for nail polish
The FDA has given the go-ahead to EMD Chemicals, a division of Merck KGaA, to market pigments that make pharmaceuticals more ?sthetically pleasing. The pearlescent pigments can produce a metallic, stained, or shimmery finish in tablets and liquids, and they come in different colors.
Pearly sheen not just for nail polish
The FDA has given the go-ahead to EMD Chemicals, a division of Merck KGaA, to market pigments that make pharmaceuticals more aesthetically pleasing. The pearlescent pigments can produce a metallic, stained, or shimmery finish in tablets and liquids, and they come in different colors. The chemicals approved are produced by coating the mineral mica with titanium dioxide or iron oxide; however, they may not account for more than 3% of the weight of the drug. The titanium dioxide coating was approved for use in June, but the FDA will continue to review pigments made with synthetic iron oxide before making a final decision. The company is also seeking approval from the agency to market the pigments in candy, chewing gum, and food.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
